BDSX
Biodesix Inc
27.70$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +14.2% | -12.0% | +32.8% | -11.3% | -5.4% | -11.3% | +1.7% | +1.1% | -1.4% | +8.2% | +0.7% | |
| – | +37.4% | -28.2% | +102.2% | -23.6% | -10.3% | -25.0% | +9.5% | +2.9% | -2.6% | +25.8% | +6.5% | |
| – | +32.5% | -56.3% | +267.4% | -25.6% | -16.4% | -32.9% | +17.8% | -19.4% | +13.7% | +34.7% | +17.3% | |
| – | +32.5% | -56.3% | +267.4% | -25.6% | -16.4% | -32.9% | +17.8% | -19.4% | +13.7% | +34.7% | +17.3% | |
| – | +32.9% | +28.8% | +2.4% | -20.7% | +7.1% | -11.2% | -2.5% | +70.1% | -28.7% | +5.1% | -3.0% | |
| – | +7.7% | +0.0% | -14.3% | +0.0% | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -6.0% | -6.7% | -6.8% | -6.5% | -8.8% | -8.8% | -9.1% | -10.2% | -11.2% | -11.1% | -13.7% | |
| – | +7.1% | -1.9% | -14.2% | -5.9% | +2.0% | -1.6% | +15.2% | +4.4% | -0.6% | -4.9% | +0.8% | |
| – | +2.3% | -6.5% | -43.8% | -26.1% | +10.4% | -7.0% | +13.8% | +19.7% | -3.9% | -16.9% | +5.5% | |
| – | -73.9% | +4.6% | +6.3% | +93.8% | +13.3% | +50.3% | +12.2% | +12.6% | -2.5% | +6.1% | +10.7% | |
| – | +0.9% | +9.7% | -30.9% | +14.3% | -13.5% | +33.3% | +1.6% | +21.7% | -14.8% | +18.5% | -40.8% | |
| – | +41.2% | +0.8% | +0.8% | +0.9% | +0.8% | +0.8% | +27.5% | +0.7% | +0.7% | -2.0% | +0.7% | |
| – | – | -220.1% | – | -23.2% | -25.1% | -47.0% | -89.7% | -251.3% | – | – | +0.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +15.8% | +5.2% | +30.9% | +15.0% | +0.2% | 0.0% | +0.1% | +2.3% | +7.5% | +19.7% | +6.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.